MEDIZEN HUMANCARE Inc. (XKON:236340)

MEDIZEN HUMANCARE Statistics

Total Valuation

XKON:236340 has a market cap or net worth of KRW 4.38 billion.

Market Cap	4.38B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

XKON:236340 has 2.30 million shares outstanding.

Current Share Class	2.30M
Shares Outstanding	2.30M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.50
PB Ratio	1.86
P/TBV Ratio	1.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.99, with a Debt / Equity ratio of 0.55.

Current Ratio	7.99
Quick Ratio	7.67
Debt / Equity	0.55
Debt / EBITDA	n/a
Debt / FCF	-0.58
Interest Coverage	-34.06

Financial Efficiency

Return on equity (ROE) is -162.65% and return on invested capital (ROIC) is -40.13%.

Return on Equity (ROE)	-162.65%
Return on Assets (ROA)	-39.15%
Return on Invested Capital (ROIC)	-40.13%
Return on Capital Employed (ROCE)	-46.89%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.22
Inventory Turnover	4.37

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.44% in the last 52 weeks. The beta is 0.04, so XKON:236340's price volatility has been lower than the market average.

Beta (5Y)	0.04
52-Week Price Change	-48.44%
50-Day Moving Average	1,813.08
200-Day Moving Average	2,376.34
Relative Strength Index (RSI)	49.90
Average Volume (20 Days)	172

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, XKON:236340 had revenue of KRW 583.88 million and -1.69 billion in losses. Loss per share was -821.00.

Revenue	583.88M
Gross Profit	358.57M
Operating Income	-1.65B
Pretax Income	-1.69B
Net Income	-1.69B
EBITDA	-1.10B
EBIT	-1.65B
Loss Per Share	-821.00

Balance Sheet

The company has 1.59 billion in cash and 1.29 billion in debt, giving a net cash position of 302.56 million or 131.27 per share.

Cash & Cash Equivalents	1.59B
Total Debt	1.29B
Net Cash	302.56M
Net Cash Per Share	131.27
Equity (Book Value)	2.35B
Book Value Per Share	1,084.81
Working Capital	1.65B

Cash Flow

In the last 12 months, operating cash flow was -903.67 million and capital expenditures -1.33 billion, giving a free cash flow of -2.23 billion.

Operating Cash Flow	-903.67M
Capital Expenditures	-1.33B
Free Cash Flow	-2.23B
FCF Per Share	-968.60

Margins

Gross margin is 61.41%, with operating and profit margins of -282.33% and -288.80%.

Gross Margin	61.41%
Operating Margin	-282.33%
Pretax Margin	-288.80%
Profit Margin	-288.80%
EBITDA Margin	-188.10%
EBIT Margin	-282.33%
FCF Margin	n/a

Dividends & Yields

XKON:236340 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-38.50%
FCF Yield	-50.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XKON:236340 has an Altman Z-Score of -1.96 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.96
Piotroski F-Score	1